Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 Diabetes

Continuous subcutaneous insulin infusion (CSII) treatment may improve long-term glycemic outcomes and enhance quality of life compared with a multiple daily injection (MDI) insulin regimen for people with type 1 diabetes. As the number of people treated with CSII via a tubeless insulin pump is incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Sanjeev N., Tinsley, Liane J., Kruger, Davida, Bode, Bruce, Layne, Jennifer E., Huyett, Lauren M., Dryga, Kate, Dumais, Bonnie, Ly, Trang T., Laffel, Lori M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839599/
https://www.ncbi.nlm.nih.gov/pubmed/33551556
http://dx.doi.org/10.2337/cd20-0022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839599/
https://www.ncbi.nlm.nih.gov/pubmed/33551556
http://dx.doi.org/10.2337/cd20-0022

Ejemplares similares